Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Current Atherosclerosis Reports|August 7, 2001
Platelet-endothelial interactions in atherosclerosisB S SachaisMolecular Pharmacology|July 1, 1994
Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708B S Sachais, J E KrauseTransfusion|April 24, 2001
Blood transfusion costs by diagnosis-related groups in 60 university hospitals in 1995L C Jefferies, B S Sachais, D S YoungClinical Chemistry|July 15, 2000
Laboratory costs in the context of diseaseD S Young, B S Sachais, L C JefferiesMolecular Pharmacology|May 1, 1995
Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responsesR M Brodbeck, B S Sachais, J E KrauseNigerian Journal of Clinical Practice|December 2, 2017
Automated (Centrifugal) therapeutic plasma exchange option for guillain-barre syndrome: A report from Calabar, NigeriaO E Iheanacho, C Chimeziem, B S Sachais, et al.The Journal of Biological Chemistry|February 5, 1993
Molecular basis for the species selectivity of the substance P antagonist CP-96,345B S Sachais, R M Snider, J A Lowe, et al.Biochemical and Biophysical Research Communications|September 30, 1991
Molecular cloning, structural characterization and functional expression of the human substance P receptorY Takeda, K B Chou, J Takeda, et al.Journal of Neurochemistry|August 1, 1992
Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in Chinese hamster ovary cells and evidence for differential stimulation of inositol 1,4,5-trisphosphate and cyclic AMP second messenger responsesY Takeda, P Blount, B S Sachais, et al.Pageof 3